Evidence map›Paper›PMID 31957537›Full record

ArticleCell adhesion & migration2020

BST2 regulates interferon gamma-dependent decrease in invasion of HTR-8/SVneo cells via STAT1 and AKT signaling pathways and expression of E-cadherin.

Sonam Verma, Amandeep Kaur Kang, Rahul Pal, Satish Kumar Gupta

Open access · goldAbstract read
In one paragraph

Article in Cell adhesion & migration, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sonam VermaReproductive Cell Biology Laboratory, National Institute of Immunology, New Delhi, India.
Amandeep Kaur KangReproductive Cell Biology Laboratory, National Institute of Immunology, New Delhi, India.
Rahul PalImmunoendocrinology Laboratory, National Institute of Immunology, New Delhi, India.
Satish Kumar GuptaReproductive Cell Biology Laboratory, National Institute of Immunology, New Delhi, India.
National Institute of Immunology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mechanism by which interferon-gamma (IFN-γ) downregulates trophoblast invasion needs further investigation. Treatment of HTR-8/SVneo cells with IFN-γ led to a decrease in their invasion concomitant with an increased expression of BST2. Silencing of BST2 by siRNA showed a significant increase in their invasion and spreading after treatment with IFN-γ as well as downregulated expression of E-cadherin. Further, STAT1 silencing inhibited the IFN-γ-dependent increase in the expression of BST2 and E-cadherin. Treatment of HTR-8/SVneo cells with IFN-γ led to the activation of AKT, and its inhibition with PI3K inhibitor abrogated IFN-γ-mediated decrease in invasion/spreading and downregulated BST2 and E-cadherin expression. Collectively, IFN-γ decreases the invasion of HTR-8/SVneo cells by STAT1 and AKT activation via increased expression of BST2 and E-cadherin.

Indexed as

Cell MovementAntigens, CDBone Marrow Stromal Antigen 2CadherinsCell LineGene SilencingGPI-Linked ProteinsHumansInterferon-gammaModels, BiologicalProto-Oncogene Proteins c-aktSignal TransductionSTAT1 Transcription FactorTrophoblastsAntigens, CDBone Marrow Stromal Antigen 2BST2 protein, humanCadherinsGPI-Linked ProteinsInterferon-gammaProto-Oncogene Proteins c-aktSTAT1 protein, humanSTAT1 Transcription FactorAKTBST2E-cadherinIFN-γSTAT1trophoblast invasion

Identifiers

PMID31957537
PMCPMC6973314
OpenAlexW3001690244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.